Critical appraisal of bilastine for the treatment of allergic rhinoconjunctivitis and urticaria
Bilastine is a second generation antihistamine indicated for the treatment of seasonal or perennial allergic rhinoconjunctivitis and chronic urticaria with a daily dose of 20 mg, in adults and children over 12 years of age. The efficacy of bilastine has been shown to be similar to that of the compar...
Main Authors: | Sadaba, B. (Belén), Azanza, J.R. (José Ramón), Gomez-Guiu, A. (Almudena), Rodil, R. (R.) |
---|---|
Format: | info:eu-repo/semantics/article |
Language: | eng |
Published: |
Dove Medical Press
2014
|
Subjects: | |
Online Access: | https://hdl.handle.net/10171/36423 |
Similar Items
-
Omalizumab, the innovative biologic that disrupted the market of the treatment of allergic diseases
by: Pérez-Herranz, I. (Irene), et al.
Published: (2023) - Reacciones a drogas
- Reacciones a drogas
-
Características de la prueba intradermocutánea positivas en pacientes con dermatosis atendidos en la Fundación Hogar del Ecuador 2015 – 2016
by: Caguana Dutan, Inocencio Jonnathan, et al.
Published: (2018) -
Naturally lignan-rich foods: a dietary tool for health promotion?
by: Rodríguez-García, C. (Carmen), et al.
Published: (2021)